These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18691678)

  • 1. Development of novel peptide inhibitor of Lipoxygenase based on biochemical and BIAcore evidences.
    Somvanshi RK; Singh AK; Saxena M; Mishra B; Dey S
    Biochim Biophys Acta; 2008 Nov; 1784(11):1812-7. PubMed ID: 18691678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unusual isotope effect on substrate inhibition in the oxidation of arachidonic acid by lipoxygenase.
    Peng S; van der Donk WA
    J Am Chem Soc; 2003 Jul; 125(30):8988-9. PubMed ID: 15369335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure based design and synthesis of peptide inhibitor of human LOX-12: in vitro and in vivo analysis of a novel therapeutic agent for breast cancer.
    Singh AK; Singh R; Naz F; Chauhan SS; Dinda A; Shukla AA; Gill K; Kapoor V; Dey S
    PLoS One; 2012; 7(2):e32521. PubMed ID: 22384268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.
    Wisastra R; Ghizzoni M; Boltjes A; Haisma HJ; Dekker FJ
    Bioorg Med Chem; 2012 Aug; 20(16):5027-32. PubMed ID: 22789707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascorbic acid 6-palmitate: a potent inhibitor of human and soybean lipoxygenase-dependent lipid peroxidation.
    Mohamed R; Tarannum S; Yariswamy M; Vivek HK; Siddesha JM; Angaswamy N; Vishwanath BS
    J Pharm Pharmacol; 2014 Jun; 66(6):769-78. PubMed ID: 24359271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Docking Analysis in the Prediction and Biological Evaluation of the Lipoxygenase Inhibitory Action of Thiazolyl Derivatives of Mycophenolic Acid.
    Tsolaki E; Eleftheriou P; Kartsev V; Geronikaki A; Saxena AK
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29970872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evaluation and docking studies of α,β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A₂, cyclooxygenases, lipoxygenase and proinflammatory cytokines.
    Bukhari SN; Lauro G; Jantan I; Bifulco G; Amjad MW
    Bioorg Med Chem; 2014 Aug; 22(15):4151-61. PubMed ID: 24938495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoxygenase-1 from soybean seed inhibiting the activity of pancreatic lipase.
    Satouchi K; Hirano K; Fujino O; Ikoma M; Tanaka T; Kitamura K
    Biosci Biotechnol Biochem; 1998 Aug; 62(8):1498-503. PubMed ID: 9757555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities.
    Pontiki E; Hadjipavlou-Litina D; Litinas K; Nicolotti O; Carotti A
    Eur J Med Chem; 2011 Jan; 46(1):191-200. PubMed ID: 21106277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory and mechanistic investigations of oxo-lipids with human lipoxygenase isozymes.
    Armstrong MM; Diaz G; Kenyon V; Holman TR
    Bioorg Med Chem; 2014 Aug; 22(15):4293-7. PubMed ID: 24924423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptic digestion of soybean lipoxygenase-1 generates a 60 kDa fragment with improved activity and membrane binding ability.
    Maccarrone M; Salucci ML; van Zadelhoff G; Malatesta F; Veldink G; Vliegenthart JF; Finazzi-Agrò A
    Biochemistry; 2001 Jun; 40(23):6819-27. PubMed ID: 11389595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural modifications of coumarin derivatives: Determination of antioxidant and lipoxygenase (LOX) inhibitory activity.
    Roussaki M; Zelianaios K; Kavetsou E; Hamilakis S; Hadjipavlou-Litina D; Kontogiorgis C; Liargkova T; Detsi A
    Bioorg Med Chem; 2014 Dec; 22(23):6586-6594. PubMed ID: 25456384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding investigation of human 5-lipoxygenase with its inhibitors by SPR technology correlating with molecular docking simulation.
    Du L; Zhang Z; Luo X; Chen K; Shen X; Jiang H
    J Biochem; 2006 Apr; 139(4):715-23. PubMed ID: 16672272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of lipoxygenase inhibition by octapeptides.
    Schurink M; van Berkel WJ; Wichers HJ; Boeriu CG
    Peptides; 2007 Dec; 28(12):2268-75. PubMed ID: 17996330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
    Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL
    Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroxydocosahexaenoic acids of the neuroprotectin D family: synthesis, structure, and inhibition of human 5-lipoxygenase.
    Butovich IA; Lukyanova SM; Bachmann C
    J Lipid Res; 2006 Nov; 47(11):2462-74. PubMed ID: 16899822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition studies of soybean and human 15-lipoxygenases with long-chain alkenyl sulfate substrates.
    Mogul R; Holman TR
    Biochemistry; 2001 Apr; 40(14):4391-7. PubMed ID: 11284695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum 5-LOX: a progressive protein marker for breast cancer and new approach for therapeutic target.
    Kumar R; Singh AK; Kumar M; Shekhar S; Rai N; Kaur P; Parshad R; Dey S
    Carcinogenesis; 2016 Sep; 37(9):912-7. PubMed ID: 27432812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
    Ding XZ; Iversen P; Cluck MW; Knezetic JA; Adrian TE
    Biochem Biophys Res Commun; 1999 Jul; 261(1):218-23. PubMed ID: 10405349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
    Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.